At the 4th Western Balkan Digital Summit (11-13 October 2021, Podgorica, Montenegro), attended by representatives from the Western Balkan (WB) countries, WHO Regional Director, Dr Hans Hanri P. Kluge, made several strategic statements regarding development of the healthcare system in the Western Balkan region.
An amendment to the law on publicly financed health care services, recently published in Journal of Laws of the Republic of Poland, envisages a gradual increase on healthcare spending from 5,75% of GDP in 2022 to 6,8% of GDP in 2026.
The e-PIL pilot project seeks to assess whether the introduction of electronic package leaflets (e-PILs) instead of printed labels with the view to ensure the safe use of hospital medicinal products and increase their availability.
NEWS REGULATORY CONSULTING PHARMACOVIGILANCE SERVICES MARKET ACCESS SERVICES MARKETING AND SALES Kazakhstan Pharmaceutical and Medical Device Market Trends In February 2018, the Bulgarian Drug Agency (BDA) announced new requirements for fee payments which are important for all applicants, marketing authorisation holders and their representatives. When requesting an administrative service for marketing authorization/registration, variations, renewals of…
The State Medicines Control Agency on the ground of market monitoring data has compiled the list of medicinal products authorized in the Republic of Lithuania which more than for three years had not been supplied to the Lithuanian market. We here with remind that following Part 7 Article 14 of the Law on Pharmacy in…
With Serbia making further progress with the EU accession process and the prospect of joining the EU in 2025, it is the country which gets increased attention of international pharmaceutical and medical device manufacturers.
Azerbaijan offers Jordan to establish a joint pharmaceutical factory, Jordan Economy Ministry said on Feb. 21.
To protect the EU pharmaceutical market from the entry of falsified medicines, the European Medicines Verification Organisation (EMVO) was created as a joint initiative of EU stakeholders, representing manufacturers, wholesalers and community pharmacists.
Slovakia’s approved Amendment to Act no. 595/2003 Coll. on Income Tax (ITA) and approved Amendment to Act no. 222/2004 Coll. on Value Added Tax (VATA), bring significant changes to the tax laws, effective 1 January 2018, which may affect pharmaceutical companies. The most relevant of these changes are:
The State Institute for Drug Control in Czech Republic (SUKL) has published the information with regard to reporting of registration holder pursuant to Section 33, paragraph 2 of Act on Pharmaceuticals. It draws the attention to the obligations set out in Act No 378/2007 Coll., on Pharmaceuticals and on Amendments to Some Related Acts (hereinafter…